$1.25 Billion is the total value of BRIDGER MANAGEMENT, LLC's 36 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 37.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AMWL | New | AMERICAN WELL CORPcl a | $137,314,000 | – | 4,632,740 | +100.0% | 10.98% | – |
NTRA | Sell | NATERA INC | $95,072,000 | +31.2% | 1,316,052 | -9.5% | 7.60% | +13.3% |
CZR | New | CAESARS ENTERTAINMENT INC NE | $75,931,000 | – | 1,354,466 | +100.0% | 6.07% | – |
GDDY | Sell | GODADDY INCcl a | $73,414,000 | +0.4% | 966,360 | -3.1% | 5.87% | -13.3% |
ALC | Buy | ALCON AG | $56,840,000 | +16.9% | 998,066 | +17.6% | 4.54% | +0.9% |
CHTR | Sell | CHARTER COMMUNICATIONS INC Ncl a | $53,293,000 | +16.8% | 85,359 | -4.6% | 4.26% | +0.9% |
ALNY | ALNYLAM PHARMACEUTICALS INC | $52,304,000 | -1.7% | 359,234 | 0.0% | 4.18% | -15.1% | |
POST | Sell | POST HLDGS INC | $47,060,000 | -6.8% | 547,211 | -5.0% | 3.76% | -19.5% |
CNC | Sell | CENTENE CORP DEL | $46,657,000 | -18.4% | 799,880 | -11.1% | 3.73% | -29.5% |
HCA | New | HCA HEALTHCARE INC | $44,649,000 | – | 358,106 | +100.0% | 3.57% | – |
ALXN | New | ALEXION PHARMACEUTICALS INC | $43,306,000 | – | 378,454 | +100.0% | 3.46% | – |
MS | MORGAN STANLEY | $39,503,000 | +0.1% | 817,030 | 0.0% | 3.16% | -13.5% | |
MRK | New | MERCK & CO. INC | $38,675,000 | – | 466,246 | +100.0% | 3.09% | – |
GDS | GDS HLDGS LTDsponsored ads | $37,634,000 | +2.7% | 459,904 | 0.0% | 3.01% | -11.3% | |
LKQ | LKQ CORP | $35,403,000 | +5.8% | 1,276,708 | 0.0% | 2.83% | -8.6% | |
VRSN | VERISIGN INC | $35,358,000 | -1.0% | 172,604 | 0.0% | 2.83% | -14.5% | |
ROST | New | ROSS STORES INC | $31,561,000 | – | 338,207 | +100.0% | 2.52% | – |
INCY | INCYTE CORP | $30,776,000 | -13.7% | 342,950 | 0.0% | 2.46% | -25.5% | |
UBER | Buy | UBER TECHNOLOGIES INC | $29,184,000 | +44.5% | 800,000 | +23.1% | 2.33% | +24.7% |
ARNA | Sell | ARENA PHARMACEUTICALS INC | $27,110,000 | -19.8% | 362,482 | -32.5% | 2.17% | -30.7% |
IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $24,965,000 | +25.8% | 2,775,467 | +44.3% | 2.00% | +8.6% |
ETSY | Sell | ETSY INC | $22,587,000 | -12.5% | 185,703 | -23.6% | 1.81% | -24.5% |
MGM | MGM RESORTS INTERNATIONAL | $20,826,000 | +29.5% | 957,528 | 0.0% | 1.66% | +11.7% | |
ATRA | Sell | ATARA BIOTHERAPEUTICS INC | $20,507,000 | -21.2% | 1,582,360 | -11.4% | 1.64% | -31.9% |
PVG | PRETIUM RES INC | $18,058,000 | +52.9% | 1,406,412 | 0.0% | 1.44% | +32.0% | |
LH | Sell | LABORATORY CORP AMER HLDGS | $16,081,000 | -70.5% | 85,413 | -74.0% | 1.29% | -74.6% |
INSP | Sell | INSPIRE MED SYS INC | $13,603,000 | -6.2% | 105,411 | -36.7% | 1.09% | -19.0% |
TEVA | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $13,515,000 | -26.9% | 1,500,000 | 0.0% | 1.08% | -36.9% | |
DXCM | Sell | DEXCOM INC | $12,893,000 | -16.1% | 31,277 | -17.5% | 1.03% | -27.5% |
LBRDA | LIBERTY BROADBAND CORP | $12,456,000 | +16.1% | 87,833 | 0.0% | 1.00% | +0.2% | |
BMYRT | Buy | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $9,961,000 | +52.4% | 4,427,269 | +142.5% | 0.80% | +31.6% |
DRNA | Sell | DICERNA PHARMACEUTICALS INC | $9,049,000 | -75.8% | 503,012 | -65.9% | 0.72% | -79.1% |
FTDR | FRONTDOOR INC | $8,755,000 | -12.2% | 225,000 | 0.0% | 0.70% | -24.2% | |
QTRX | Sell | QUANTERIX CORP | $7,024,000 | +4.2% | 208,185 | -15.4% | 0.56% | -9.9% |
TGTX | Sell | TG THERAPEUTICS INC | $6,875,000 | -48.8% | 256,897 | -62.8% | 0.55% | -55.8% |
ALEC | New | ALECTOR INC | $2,414,000 | – | 229,117 | +100.0% | 0.19% | – |
BRBR | Exit | BELLRING BRANDS INC | $0 | – | -100,000 | -100.0% | -0.18% | – |
FWONK | Exit | LIBERTY MEDIA CORP DEL | $0 | – | -116,440 | -100.0% | -0.34% | – |
WORK | Exit | SLACK TECHNOLOGIES INC | $0 | – | -611,713 | -100.0% | -1.76% | – |
REGN | Exit | REGENERON PHARMACEUTICALS | $0 | – | -56,053 | -100.0% | -3.24% | – |
UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -145,627 | -100.0% | -3.98% | – |
ERI | Exit | ELDORADO RESORTS INC | $0 | – | -1,354,466 | -100.0% | -5.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VERISIGN INC | 40 | Q1 2023 | 5.2% |
TEVA PHARMACEUTICAL INDS LTD | 40 | Q3 2023 | 7.3% |
MORGAN STANLEY | 35 | Q3 2023 | 11.8% |
ALNYLAM PHARMACEUTICALS INC | 34 | Q3 2021 | 4.9% |
POST HLDGS INC | 33 | Q4 2022 | 6.1% |
TG THERAPEUTICS INC | 33 | Q3 2021 | 3.8% |
CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 7.2% |
ATARA BIOTHERAPEUTICS INC | 29 | Q4 2021 | 6.4% |
GODADDY INC | 28 | Q3 2023 | 8.9% |
CENTENE CORP DEL | 28 | Q3 2022 | 6.2% |
View BRIDGER MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Surrozen, Inc./DESold out | February 14, 2022 | 0 | 0.0% |
Atara Biotherapeutics, Inc. | February 16, 2021 | 1,524,760 | 1.8% |
Dicerna Pharmaceuticals Inc | February 14, 2020 | 1,981,633 | 2.9% |
TG THERAPEUTICS, INC. | February 14, 2020 | 1,907,492 | 1.9% |
CHIMERIX INCSold out | February 14, 2017 | 0 | 0.0% |
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold out | February 14, 2017 | 0 | 0.0% |
SeaSpine Holdings CorpSold out | February 14, 2017 | 0 | 0.0% |
Trovagene, Inc.Sold out | February 14, 2017 | 0 | 0.0% |
ARROWHEAD RESEARCH CORPSold out | February 16, 2016 | 0 | 0.0% |
PENNYMAC FINANCIAL SERVICES, INC.Sold out | February 16, 2016 | 0 | 0.0% |
View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR/A | 2024-03-25 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
View BRIDGER MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.